EPISODE · Sep 15, 2025 · 25 MIN
EP 34: Groundbreaking MACE Study: The Role of the GlycoCheck Device in Predicting Cardiovascular Events with Dr. Hans and Joelyn Beaver, Part 1
from The Future of Vascular Health brought to you by Glycocalyx Research Institute · host Robert Long
Most of us know about cholesterol, blood pressure, and blood sugar as risk factors for cardiovascular disease. But what if there was an earlier, more powerful marker—one that could predict heart attacks, strokes, or even survival in the ICU years before they happen?In this episode, we’re joined by Dr. Hans Vink and Jolynn Beaver to discuss groundbreaking research from the MACE study in Greece, where 600 individuals were tracked over six years. Using the GlycoCheck device, scientists measured the health of the glycocalyx—the protective inner lining of your blood vessels—and found it could predict future cardiovascular events in otherwise “healthy” people.This is the first time glycocalyx health has been validated in such a large, long-term study. The implications are massive for prevention, functional medicine, and patients who feel dismissed by “normal labs” yet know something deeper is wrong.What You’ll Learn in This EpisodeWhat the glycocalyx is and why it’s the body’s most overlooked defense system.How a simple, non-invasive GlycoCheck scan can reveal hidden vascular risk.Why even “healthy” people with normal labs may still be at risk for strokes or heart attacks.How chronic conditions like diabetes, hypertension, and stroke all trace back to glycocalyx damage.The connection between microvascular health and outcomes in COVID, sepsis, and cancer treatment.Real-world examples of patients and practitioners seeing life-changing results with GlycoCheck and ReVasca.00:00 Vascular Future00:59 MACE Study Intro03:05 Glycocalyx Explained11:22 Device Demo16:00 Disease Insights21:52 Groundbreaking Study24:52 Take the Quiz25:41 Closing ThoughtsWhy This MattersPatients everywhere report fatigue, brain fog, cold hands and feet, or blood pressure instability—only to be told their labs look “normal.” The MACE study proves what they’ve felt all along: microvascular damage begins long before standard diagnostics catch it.This research is a turning point in functional and preventive medicine. It gives practitioners the ability to see the health you can’t feel—and empowers patients to act early, not after a crisis.“The problems are complicated. The solutions are simple. A strong vascular system underpins every aspect of health.” — Dr. Hans Vink“Like a frayed charging cord, your energy can’t flow if your microcirculation is blocked. The glycocalyx is the foundation.” — Joelynn BeaverCheck your vascular health here: http://www.revascaquiz.com Learn more here: https://glycocalyx.com/
Embed this episode
Ready to play
EP 34: Groundbreaking MACE Study: The Role of the GlycoCheck Device in Predicting Cardiovascular Events with Dr. Hans and Joelyn Beaver, Part 1
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.